AgBiome, an agricultural technology firm that harnesses plant microbiomes to develop novel crop protection products, has landed $116 million in funding. The oversubscribed Series D round was co-led by Blue Horizon and Novalis LifeSciences and included multiple new and existing investors.
Capital will go toward “developing proprietary products, fostering partner programs, joint ventures, and new company formations,” the company said. “Biologicals are a rapidly growing, disruptive market segment that is projected to grow 14-fold by 2030,” said Scott Uknes, AgBiome co-founder.
“Growers need new tools to control problematic diseases while ensuring effective resistance management. AgBiome is laser-focused on developing science-based solutions.
AgBiome uses the plant microbiome to identify and develop genetic traits that provide resistance to pests. Its Genesis platform screens trillions of microbes, millions of gene sequences, and thousands of strains. It has discovered 3,500 new insect control genes and 200 active lead strains.
AgBiome104 T. W. Alexander Drive,
Building 1
Research Triangle Park, NC 27709